1 – 10 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers
- Blood glucose and hypertension development : the hen and egg controversy
- 2018
- Characteristics of healthy vascular ageing in pooled population-based cohort studies : the global Metabolic syndrome and Artery REsearch Consortium
- 2016
- DPP-4 inhibition and blood pressure lowering in perspective.
- A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity.
- Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
- 2015
- Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.
- Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension.
- Non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the Malmö Diet and Cancer study.
- Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and early vascular ageing.